PADI4 and neoplasm: Cl-amidine [56], and the related PAD4 inhibitor, F-amidine [57], display low micromolar cytotoxicity towards various tumor cell lines such as U2OS cells, HL-60, HT-29, and MCF-7 [29, 55, 58].